Complement Component C1qA Antibody (004-43.X (3R9/2)) - BSA Free

Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.

Flow Cytometry: Complement Component C1qA Antibody (3R9/2) [NB100-64729]

• Reactivity: Hu
• Applications: WB, ELISA, Flow, IHC
• Clone: 004-43.X (3R9/2)
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1.0 mg/ml

Complement Component C1qA Antibody (004-43.X (3R9/2)) - BSA Free Summary

• Description: Novus Biologicals Mouse Complement Component C1qA Antibody (004-43.X (3R9/2)) - BSA Free (NB100-64729) is a monoclonal antibody validated for use in IHC, WB, ELISA and Flow. Anti-Complement Component C1qA Antibody: Cited in 6 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.
• Immunogen: Globular head domain of C1q, purified from human plasma
• Specificity: Recognizes human complement component 1 q (C1q), a 156kDa secreted protein.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: C1QA
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:100-1:2000
  • Flow Cytometry 1:10-1:1000
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Frozen 1:500-1:1000
  • Western Blot 1:100-1:2000
• Control:

  C1q Overexpression Lysate

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: Borate buffered saline
• Preservative: <0.1% Sodium Azide
• Concentration: 1.0 mg/ml
• Purity: Protein A purified

Alternate Names for Complement Component C1qA Antibody (004-43.X (3R9/2)) - BSA Free

• C1QA complement component 1, q subcomponent, A chain
• C1QA
• Complement Component C1qA

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Complement Component C1qA Antibody (NB100-64729)(6)

Publications using NB100-64729

• Brandin AC, Meola SD, Mazzaferro EM. et Al. Respiratory arrest following ingestion of wild mushrooms in 3 dogs (2006-2011) J Vet Emerg Crit Care (San Antonio) 2014-08-21 [PMID: 24102893]
• Castellano, G et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. 2010-01-01 [PMID: 20150432]
• Kerr RL, Miller SA, Shoemaker RK et al. New type of Li ion conductor with 3D interconnected nanopores via polymerization of a liquid organic electrolyte-filled lyotropic liquid-crystal assembly. 2010-01-07 [PMID: 19839612]
• Moreno-Vinasco L, Gomberg-Maitl M, Maitl ML et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics;33(2):278-91. 2008-04-22 [PMID: 18303084]
• Gershov, D et al. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. 2000-01-01 [PMID: 11067883]
• Petry, F. Molecular basis of hereditary C1q deficiency. 1998-01-01 [PMID: 9777412]

Bioinformatics

• Gene Symbol: C1QA
• Entrez:
  • 712(Human)
• Uniprot:
  • P02745()